Los Angeles Capital Management LLC Arcutis Biotherapeutics, Inc. Transaction History
Los Angeles Capital Management LLC
- $24.7 Billion
- Q3 2024
A detailed history of Los Angeles Capital Management LLC transactions in Arcutis Biotherapeutics, Inc. stock. As of the latest transaction made, Los Angeles Capital Management LLC holds 125,103 shares of ARQT stock, worth $1.77 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
125,103
Previous 135,948
7.98%
Holding current value
$1.77 Million
Previous $1.26 Million
7.99%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding ARQT
# of Institutions
197Shares Held
129MCall Options Held
738KPut Options Held
82K-
Jennison Associates LLC11.7MShares$165 Million0.07% of portfolio
-
Rubric Capital Management LP New York, NY11MShares$155 Million2.84% of portfolio
-
Suvretta Capital Management, LLC New York, NY10.7MShares$151 Million3.92% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA8.79MShares$124 Million4.4% of portfolio
-
Black Rock Inc. New York, NY8.62MShares$122 Million0.0% of portfolio
About Arcutis Biotherapeutics, Inc.
- Ticker ARQT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,187,500
- Market Cap $849M
- Description
- Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing A...